Atropine Sulfate 51662-1619
Product NDC
51662-1619- Manufacturer
- Hf Acquisition Co Llc, Dba Healthfirst
- Dosage Form
- Injection
- Route
- Endotracheal, Intramedullary, Intramuscular, Intravenous, And Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 1, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA213561
Need to source Atropine Sulfate? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Atropine Sulfate | .4 mg/mL |
Drug Class
Anticholinergic [EPC]Cholinergic Antagonists [MoA]Cholinergic Muscarinic Antagonist [EPC]
Packaging Options(2)
20 mL in 1 VIAL (51662-1619-1)
10 POUCH in 1 CASE (51662-1619-3) / 1 VIAL in 1 POUCH (51662-1619-2) / 20 mL in 1 VIAL